Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “System and method for creating a decision support material indicating damage to an anatomical joint”, relates to surgical pre-planning and 3D-based assessment of joint lesions, and complements Episurf Medical’s earlier US patents within this field.

“With this we get additional protection in the US within medical imaging and surgical pre-planning, not only related to the company’s Episealer® implants but with a broader scope, showing Episurf’s software capabilities. We are constantly reviewing various commercial initiatives within this field, hence we are pleased with this patent”, comments Katarina Flodström, COO, Episurf Medical.